C12N 2820/55
From bacteria
Official title: from bacteria
C12N2820/55 (From bacteria) appears on 48 US grants and 87 published applications in this corpus.
Search patents in C12N- Granted patents
- 48
- Published applications
- 87
- Assignees
- 45
- Inventors
- 143
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 4 |
| 2009 | 0 | 1 |
| 2010 | 2 | 2 |
| 2011 | 0 | 3 |
| 2012 | 1 | 3 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 6 |
| 2016 | 2 | 5 |
| 2017 | 4 | 8 |
| 2018 | 3 | 4 |
| 2019 | 4 | 6 |
| 2020 | 4 | 8 |
| 2021 | 2 | 6 |
| 2022 | 1 | 5 |
| 2023 | 10 | 9 |
| 2024 | 2 | 4 |
| 2025 | 7 | 7 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mammalian expression vectors30 Jun 2026US 12,668,809 B2Biocon Biologics Limited
- Viral and non-viral nanoplasmid vectors with improved production14 Apr 2026US 12,600,984 B2Aldevron, LLC
- Large vectors and methods for high-yield production10 Mar 2026US 12,570,990 B2Katholieke Universiteit Leuven
- System and process for in vivo manufacturing nanostructure-ended double-stranded covalently-closed linear DNA, the resulting molecules and their uses30 Dec 2025US 12,509,711 B1Syste.Bio Inc.
- Non-immunogenic circular, non-viral DNA vectors18 Nov 2025US 12,473,567 B2Rampart Bioscience, Inc.
- Viral and non-viral nanoplasmid vectors with improved production24 Sep 2026US 2026/0286384 A1Aldevron, LLC
- Single-vector type i vectors22 Jan 2026US 2026/0022389 A1SNIPR Biome ApS
- Methods and compositions to prevent microbial infection13 Nov 2025US 2025/0346910 A1Commense Bio, Inc.
- Expression and secretion system30 Oct 2025US 2025/0333723 A1Genentech, Inc.
- Compositions and methods for recombinant aav production3 Jul 2025US 2025/0215401 A1REGENXBIO Inc.
Most cited
By later US patents
- DNA plasmids with improved expression26US 9,550,998 B2Nature Technology Corporation · 2017
- Plasmid for delivery of nucleic acids to cells and methods of use21US 5,763,270 AGenemedicine Co., Ltd. · 1998
- Single-vector type I vectors10US 11,578,333 B2SNIPR Biome ApS · 2023
- Single-vector type I vectors10US 11,629,350 B2SNIPR Biome ApS · 2023
- Replicative minicircle vectors with improved expression8US 10,047,365 B2Nature Technology Corporation · 2018